Critical care management of traumatic brain injury Handbook of Clinical Neurology 2017 Final submitted version corrected for changes during editorial processing (with the permission of the publishers) DK Menon1,* and A Ercole1 1Division of Anaesthesia, University of Cambridge and Neurosciences/Trauma Critical Care Unit, Addenbrooke's Hospital,Cambridge, UK *Corresponding author. Email
[email protected] Abstract Traumatic brain injury (TBI) is a growing global problem, which is responsible for a substantial burden of disability and death, and which generates substantial healthcare costs. High-quality intensive care can save lives and improve the quality of outcome. TBI is extremely heterogeneous in terms of clinical presentation, pathophysiology, and outcome. Current approaches to the critical care management of TBI are not underpinned by high-quality evidence, and many of the current therapies in use have not shown benefit in randomized control trials. However, observational studies have informed the development of authoritative international guidelines, and the use of multimodality monitoring may facilitate rational approaches to optimizing acute physiology, allowing clinicians to optimize the balance between benefit and risk from these interventions in individual patients. Such approaches, along with the emerging impact of advanced neuroimaging, genomics, and protein biomarkers, could lead to the development of precision medicine approaches to the intensive care management of TBI. 1 Introduction Traumatic brain injury (TBI) is an important cause for admission to intensive care units (ICUs) in general, and to neurocritical care units in particular. National population-based figures for ICU caseload (as opposed to more specific stratification into mild, moderate, or severe TBI) are difficult to find, but the UK Intensive Care National Audit and Research Centre (ICNARC, 2015) reported that in 2014{2015, approximately 2% of all ICU admissions and about 10% of admissions to neurocritical care units were due to TBI.